James Wason

Adaptive designs in clinical trials: why use them, and how to run and report them

Philip Pallmann, Alun Bedding, Babak Choodari‐Oskooei et al. · BMC Medicine · 2018 · 834 citations · Full text

Public Health, Biostatistics, Evidence-based Practice +10

Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process

Miles D. Witham, Eleanor Anderson, Camille Carroll et al. · Trials · 2020 · 277 citations · Full text

Medicine, Health Services Administration, Evidence-based Practice +16

Imaging breast cancer using hyperpolarized carbon-13 MRI

Ferdia A. Gallagher, Ramona Woitek, Mary A. McLean et al. · Proceedings of the National Academy of Sciences · 2020 · 205 citations · Full text

Medicine, Oncology, Radiology +16

Multi-armed Bandit Models for the Optimal Design of Clinical Trials: Benefits and Challenges.

Sofía S. Villar, Jack Bowden, James Wason · Apollo (University of Cambridge) · 2015 · 181 citations · Full text

Business, Biostatistics, Decision Sciences +14

The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design

Munyaradzi Dimairo, Philip Pallmann, James Wason et al. · BMJ · 2020 · 158 citations · Full text

Public Health, Biostatistics, Evidence-based Practice +16